AHSEN BUTT: Open Payments
NPI 1528001633 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 54 payments from 13 companies in 2025. Trend: 2023 $752 · 2024 $938 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $145 |
| GlaxoSmithKline, LLC. | 15 | $135 |
| Dexcom, Inc. | 5 | $126 |
| Travere Therapeutics, Inc. | 5 | $82 |
| Grifols USA, LLC | 3 | $77 |
| Lilly USA, LLC | 4 | $75 |
| PFIZER INC. | 3 | $55 |
| Novo Nordisk Inc | 2 | $52 |
| Abbott Laboratories | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: Dexcom G6 Transmitter, TRELEGY ELLIPTA, JARDIANCE, Prolastin-C Liquid, UBRELVY, Ozempic, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across KY — which companies pay providers there.
